News Seoulin Bioscience Co.,Ltd.

Equities

A038070

KR7038070009

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
8,950 ^KRW	+0.56%		+4.31%	-2.72%

Mar. 20	Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-15	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index	22-09-19	CI
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.	22-08-07	CI
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors	22-07-21	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	21-11-23	CI
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	21-11-21	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-14	CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index	21-09-20	CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.	20-06-11	CI
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.	20-02-10	CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.	20-02-07	CI
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.	19-08-08	CI
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.	19-08-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Seoulin Bioscience Co.,Ltd.

Equities

A038070

KR7038070009

Summary

Filters